Sana Biotechnology Stock Market Value
| SANA Stock | USD 2.61 0.26 11.06% |
| Symbol | Sana |
Sana Biotechnology Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sana Biotechnology. If investors know Sana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sana Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.40) | Return On Assets (0.31) | Return On Equity (0.93) |
The market value of Sana Biotechnology is measured differently than its book value, which is the value of Sana that is recorded on the company's balance sheet. Investors also form their own opinion of Sana Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Sana Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sana Biotechnology's market value can be influenced by many factors that don't directly affect Sana Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sana Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sana Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sana Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Sana Biotechnology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Sana Biotechnology's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Sana Biotechnology.
| 11/29/2023 |
| 11/23/2024 |
If you would invest 0.00 in Sana Biotechnology on November 29, 2023 and sell it all today you would earn a total of 0.00 from holding Sana Biotechnology or generate 0.0% return on investment in Sana Biotechnology over 360 days. Sana Biotechnology is related to or competes with Olema Pharmaceuticals, Cullinan Oncology, Zentalis Pharmaceuticals, X4 Pharmaceuticals, Terns Pharmaceuticals, Day One, and Hookipa Pharma. Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines More
Sana Biotechnology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Sana Biotechnology's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Sana Biotechnology upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.27) | |||
| Maximum Drawdown | 23.4 | |||
| Value At Risk | (8.07) | |||
| Potential Upside | 7.2 |
Sana Biotechnology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Sana Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Sana Biotechnology's standard deviation. In reality, there are many statistical measures that can use Sana Biotechnology historical prices to predict the future Sana Biotechnology's volatility.| Risk Adjusted Performance | (0.17) | |||
| Jensen Alpha | (1.30) | |||
| Total Risk Alpha | (1.80) | |||
| Treynor Ratio | (0.63) |
Sana Biotechnology Backtested Returns
Sana Biotechnology owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.25, which indicates the firm had a -0.25% return per unit of risk over the last 3 months. Sana Biotechnology exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sana Biotechnology's Coefficient Of Variation of (422.73), variance of 20.74, and Risk Adjusted Performance of (0.17) to confirm the risk estimate we provide. The entity has a beta of 1.74, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Sana Biotechnology will likely underperform. At this point, Sana Biotechnology has a negative expected return of -1.13%. Please make sure to validate Sana Biotechnology's accumulation distribution, and the relationship between the potential upside and day median price , to decide if Sana Biotechnology performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.65 |
Very good reverse predictability
Sana Biotechnology has very good reverse predictability. Overlapping area represents the amount of predictability between Sana Biotechnology time series from 29th of November 2023 to 27th of May 2024 and 27th of May 2024 to 23rd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Sana Biotechnology price movement. The serial correlation of -0.65 indicates that roughly 65.0% of current Sana Biotechnology price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.65 | |
| Spearman Rank Test | -0.75 | |
| Residual Average | 0.0 | |
| Price Variance | 1.63 |
Sana Biotechnology lagged returns against current returns
Autocorrelation, which is Sana Biotechnology stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Sana Biotechnology's stock expected returns. We can calculate the autocorrelation of Sana Biotechnology returns to help us make a trade decision. For example, suppose you find that Sana Biotechnology has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Sana Biotechnology regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Sana Biotechnology stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Sana Biotechnology stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Sana Biotechnology stock over time.
Current vs Lagged Prices |
| Timeline |
Sana Biotechnology Lagged Returns
When evaluating Sana Biotechnology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Sana Biotechnology stock have on its future price. Sana Biotechnology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Sana Biotechnology autocorrelation shows the relationship between Sana Biotechnology stock current value and its past values and can show if there is a momentum factor associated with investing in Sana Biotechnology.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Sana Biotechnology offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sana Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sana Biotechnology Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sana Biotechnology Stock:Check out Sana Biotechnology Correlation, Sana Biotechnology Volatility and Sana Biotechnology Alpha and Beta module to complement your research on Sana Biotechnology. For information on how to trade Sana Stock refer to our How to Trade Sana Stock guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Sana Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.